Concepedia

Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial

Marcia M. L. Kho, A. Lianne Messchendorp, Sophie C. Frölke, Céline Imhof, Vera JCH Koomen, S. Reshwan K. Malahe, Priya Vart, Daryl Geers, Rory D. de Vries, Corine H. GeurtsvanKessel,

The Lancet Infectious Diseases · 2022 · 74 citations · 27 references

DOIFull text

Open access

Concepts

References

27

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

David S. Khoury, Deborah Cromer, Arnold Reynaldi et al. · Nature Medicine · 2021 · 4.2K citations · Full text

, , +16

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

Lisa A. Jackson, Evan J. Anderson, Nadine Rouphael et al. · New England Journal of Medicine · 2020 · 3.5K citations · Full text

, , +17

Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19

New England Journal of Medicine · 2022 · 666 citations · Full text

, , +17

Homologous and Heterologous Covid-19 Booster Vaccinations

Robert L. Atmar, Kirsten E. Lyke, Meagan E. Deming et al. · New England Journal of Medicine · 2022 · 618 citations · Full text

, , +17

SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients

Daryl Geers, Marc C. Shamier, Susanne Bogers et al. · Science Immunology · 2021 · 593 citations · Full text

, , +13